博拓生物股价涨5.46%，富国基金旗下1只基金重仓，持有61.38万股浮盈赚取146.69万元

Group 1 - The core viewpoint of the news is that Botao Bio has seen a stock price increase of 5.46%, reaching 46.20 CNY per share, with a total market capitalization of 6.899 billion CNY [1] - Botao Bio, established on November 28, 2008, specializes in the research, production, and sales of POCT diagnostic reagents, with 100% of its revenue derived from POCT products [1] Group 2 - According to data, the Fuqua Fund holds a significant position in Botao Bio, with 613,800 shares representing 4.27% of the fund's net value, making it the ninth-largest holding [2] - The Fuqua Fund has achieved a year-to-date return of 64.11%, ranking 525 out of 8,155 in its category, and a one-year return of 63.45%, ranking 484 out of 8,031 [2] Group 3 - The fund managers of Fuqua Fund are Yang Dong and Meng Hao, with Yang having a tenure of 10 years and 76 days, and Meng having a tenure of 3 years and 278 days [3] - Yang's fund has a total asset size of 9.809 billion CNY, with the best return during his tenure being 329.8% and the worst being -38.34% [3] - Meng's fund has a total asset size of 4.565 billion CNY, with the best return during his tenure being 40.12% and the worst being -2.59% [3]